COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know.

J Mol Cell Cardiol. 2020 Apr 24. pii: S0022-2828(20)30117-6!

Endothelial cell infection and endotheliitis in COVID-19

Lancet. 2020 Apr 20. pii: S0140-6736(20)30937-5.

COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers What Is the Evidence?

Circ Res. 2020 Apr 17.

Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review.

J Card Surg. 2020 Apr 19.

COVID-19 and the cardiovascular system.

Nat Rev Cardiol. 2020 May;17(5):259-260.

Management of Acute Myocardial Infarction During the COVID-19 Pandemic.

J Am Coll Cardiol. 2020 Apr 18. pii: S0735-1097(20)35026-9.

Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective.

Eur Heart J. 2020 Apr 22. pii: ehaa342.

Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response.

Curr Cardiol Rep. 2020 Apr 21;22(5):32.

Cardiovascular complications in COVID-19

Am J Emerg Med. 2020 Apr 18. pii: S0735-6757(20)30277-1

Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19.

Circ Res. 2020 Apr 17.

Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword?

FASEB J. 2020 Apr 19.

Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin Converting Enzyme 2.

J Cardiovasc Pharmacol. 2020 Apr 13.

doi: 10.1097/FJC.0000000000000840

Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence.

Eur Heart J. 2020 Apr 23. pii: ehaa335

Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement from the Heart Failure Society of America.

J Card Fail. 2020 Apr 18. pii: S1071-9164(20)30367-5

Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature.

Int J Stroke. 2020 Apr 20:1747493020921664

Adapting to a novel disruptive threat: Nuclear Cardiology Service in the time of the Coronavirus (COVID-19) Outbreak 2020 (SARS REBOOT).

J Nucl Cardiol. 2020 Apr 19.

The impact of 2019 novel coronavirus on heart injury: A systemic review and Meta-analysis.

Prog Cardiovasc Dis. 2020 Apr 16. pii: S0033-0620(20)30080-3

Disruptive Modifications to Cardiac Critical Care Delivery During the Covid-19 Pandemic: An International Perspective.

J Am Coll Cardiol. 2020 Apr 14. pii: S0735-1097(20)35002-6

Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.

Circulation. 2020 Apr 16.

Comentarios desactivados en SISTEMA CARDIOVASCULAR Y COVID-19